'Sell' Tata Chemicals Shares, Maintains Nirmal Bang Post Q1 Results — Check Target Price
Tata Chemicals Q1 FY26 consolidated adjusted PAT (including Tat Chemicals' share of Rallis – Unrated) at Rs 2.5 billion beat Nirmal Bang/ street estimates by 150.9%/101.4%. This was due to 27.9% beat on Ebitda and 371 bps beat on Ebitda margin aided by the beat in gross margin. Ebitda at Rs 6.49 billion, was a beat of 27.9%/18.3% vs brokerage/street estimates.
NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
We retain Sell on Tata Chemicals Ltd., despite the 11.8% hike in our SOTP-based target price to Rs 761 - based on raised estimates in FY26- increase in the chemistry segment EV/Ebitda from 7x to 8x post roll over to Jun'27E.
The new EV/E implies P/E of 17.6x on June'27E vs median P/E of 18.5x. The global excess capacity is hurting Soda Ash prices/margins, which is likely to cap the stock after the 14% rally in three months.
Asian soda ash prices at $160-170/te are below the cash cost. This may force closures in unviable synthetic plants, especially in Europe. The management also called for closures in unviable synthetic plants in China, post the new Inner-Mongolia mining capacities.
Hence the recovery in pricing is still some time away, while benign costs may help stabilise margins.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.